Jeffrey L. Wade

2023

In 2023, Jeffrey L. Wade earned a total compensation of $2M as President and Chief Financial Officer at Lexicon Pharmaceuticals, a 1% decrease compared to previous year.

Compensation breakdown

Bonus$200,097
Option Awards$852,786
Salary$535,729
Stock Awards$358,036
Other$16,220
Total$1,962,868

Wade received $852.8K in option awards, accounting for 43% of the total pay in 2023.

Wade also received $200.1K in bonus, $535.7K in salary, $358K in stock awards and $16.2K in other compensation.

Rankings

In 2023, Jeffrey L. Wade's compensation ranked 499th out of 2,248 executives tracked by ExecPay. In other words, Wade earned more than 77.8% of executives.

ClassificationRankingPercentile
All
499
out of 2,248
78th
Division
Manufacturing
281
out of 1,223
77th
Major group
Chemicals And Allied Products
194
out of 687
72nd
Industry group
Drugs
192
out of 658
71st
Industry
Pharmaceutical Preparations
122
out of 472
74th

Pay ratio

Jeffrey L. Wade's Pay$1,962,868
Median Employee's Pay$206,303
Pay Ratio

10

to 1

In 2023, the annual total compensation of Jeffrey L. Wade was $1,962,868.

The annual total compensation of the median employee at Lexicon Pharmaceuticals was $206,303.

The ratio of Jeffrey L. Wade's pay to the pay of median employee was therefore 10 to one.

Source: SEC filing on March 26, 2024.

Wade's colleagues

We found four more compensation records of executives who worked with Jeffrey L. Wade at Lexicon Pharmaceuticals in 2023.

2023

Lonnel Coats

Lexicon Pharmaceuticals

Chief Executive Officer

2023

Craig Granowitz

Lexicon Pharmaceuticals

Chief Medical Officer

2023

Brian Crum

Lexicon Pharmaceuticals

General Counsel

2023

Alan Main

Lexicon Pharmaceuticals

Executive Vice President, Innovation and Chemical Sciences

News

You may also like